California Institute for Regenerative Medicine Investors
The California Institute for Regenerative Medicine (CIRM) is a state agency that provides funding for stem cell research at California universities and research institutions. Established in 2005 through Proposition 71, CIRM's main goal is to support and advance stem cell research and regenerative medicine. They aim to discover and develop cures, therapies, diagnostics, and research technologies to alleviate human suffering from chronic diseases and injuries. CIRM has made significant achievements in funding clinical trials for various conditions, including cancer, diabetes, and rare diseases. Their impact extends beyond research, as they have also contributed to job creation and economic growth in California.
Invests into
Number Of Exists:
8
Investor Type:
Healthcare Company
Employee Number:
11-50
Founded Date:
2005
Industry:
AI Pharma
Headquarters:
San Francisco, California, United States